CN111529450A - 深层补水修复组合物,其护肤品及制备方法 - Google Patents
深层补水修复组合物,其护肤品及制备方法 Download PDFInfo
- Publication number
- CN111529450A CN111529450A CN202010511800.5A CN202010511800A CN111529450A CN 111529450 A CN111529450 A CN 111529450A CN 202010511800 A CN202010511800 A CN 202010511800A CN 111529450 A CN111529450 A CN 111529450A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- composition
- deep
- skin care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 58
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 30
- 230000008439 repair process Effects 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 238000004519 manufacturing process Methods 0.000 title description 2
- 239000000284 extract Substances 0.000 claims abstract description 47
- 239000003906 humectant Substances 0.000 claims abstract description 18
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 235000020221 chamomile extract Nutrition 0.000 claims abstract description 6
- 229940119217 chamomile extract Drugs 0.000 claims abstract description 6
- 240000008632 Cota tinctoria Species 0.000 claims abstract description 5
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 5
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 5
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 5
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 5
- 229940064064 purslane extract Drugs 0.000 claims abstract description 5
- 244000144927 Aloe barbadensis Species 0.000 claims abstract description 4
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 4
- 241000167550 Centella Species 0.000 claims abstract description 4
- 244000270673 Pelargonium graveolens Species 0.000 claims abstract description 4
- 235000017927 Pelargonium graveolens Nutrition 0.000 claims abstract description 4
- 229940084750 sophora flavescens root extract Drugs 0.000 claims abstract description 4
- 229940039697 alkanna tinctoria root extract Drugs 0.000 claims abstract description 3
- 239000000047 product Substances 0.000 claims description 19
- 239000006071 cream Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 102000008186 Collagen Human genes 0.000 claims description 13
- 108010035532 Collagen Proteins 0.000 claims description 13
- 229920001436 collagen Polymers 0.000 claims description 13
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 10
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 10
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 244000146462 Centella asiatica Species 0.000 claims description 9
- 235000004032 Centella asiatica Nutrition 0.000 claims description 9
- 102000015636 Oligopeptides Human genes 0.000 claims description 9
- 108010038807 Oligopeptides Proteins 0.000 claims description 9
- 230000036571 hydration Effects 0.000 claims description 9
- 238000006703 hydration reaction Methods 0.000 claims description 9
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 claims description 8
- 239000004229 Alkannin Substances 0.000 claims description 8
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 claims description 8
- 235000019232 alkannin Nutrition 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 3
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 claims description 3
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 3
- 229940090813 madecassoside Drugs 0.000 claims description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 2
- 229960000458 allantoin Drugs 0.000 claims description 2
- 229940024606 amino acid Drugs 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 229940106189 ceramide Drugs 0.000 claims description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 229940001447 lactate Drugs 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 claims description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 claims description 2
- 229940045136 urea Drugs 0.000 claims description 2
- 230000003592 biomimetic effect Effects 0.000 claims 4
- 239000004909 Moisturizer Substances 0.000 claims 3
- 230000001333 moisturizer Effects 0.000 claims 3
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical group 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 239000000419 plant extract Substances 0.000 abstract description 5
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 3
- 208000026935 allergic disease Diseases 0.000 abstract description 3
- 230000007815 allergy Effects 0.000 abstract description 3
- 239000002085 irritant Substances 0.000 abstract description 3
- 230000001914 calming effect Effects 0.000 abstract description 2
- 231100000021 irritant Toxicity 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 46
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 206010015150 Erythema Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241001506047 Tremella Species 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 235000014104 aloe vera supplement Nutrition 0.000 description 3
- 230000003467 diminishing effect Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000192656 Nostoc Species 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 241000908178 Tremella fuciformis Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 2
- 229940022757 asiaticoside Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229930015582 oxymatrine Natural products 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 230000001235 sensitizing effect Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 241000692870 Inachis io Species 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 241000452732 Nostoc sphaeroides Species 0.000 description 1
- 240000004277 Pelargonium radens Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 241001523348 Picrasma Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940105040 geranium extract Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- -1 hydroxy asiaticoside Chemical compound 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 150000003398 sorbic acids Chemical class 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及一种深层补水修复组合物,其护肤品及制备方法,所述深层补水修复组合物的原料组分包括:积雪草根提取物4‑6重量份、紫草根提取物0.1‑0.2重量份、薄荷叶提取物1‑2重量份、金黄洋甘菊提取物1‑2重量份、马齿苋提取物1‑2重量份、苦参根提取物1‑2重量份、库拉索芦荟提取物1‑2重量份、香叶天竺葵提取物1‑2重量份、仿生类保湿剂6.01‑6.03重量份、溶剂10‑16重量份、非仿生类保湿剂12‑16重量份。本发明所述的深层补水修复组合物,通过将植物提取成分与仿生类保湿剂进行复配,最终形成的组合物,具有较好的补水保湿、退红舒敏、镇定以及修复受损肌肤的作用,且易于添加于护肤品中,能轻松制备出外观漂亮的护肤品,安全温和无刺激。
Description
技术领域
本发明属于化妆品技术领域,具体涉及一种深层补水修复组合物,其护肤品及制备方法。
背景技术
随着年龄的增长,皮肤含水率逐渐下降,这直接导致了肌肤干燥、发黄、粗糙、松弛以及皱纹早生的现象。因此,补水保湿,提高肌肤含水量是抗衰的关键,也是使得其它一切功能宣称的护肤品真正发挥作用的基础。
CN111000763A公开了一种植物保湿组合物及其制备方法和应用,所述植物保湿组合物包括如下质量份数的组分:高分子量银耳子实体提取物0.1~5份,低分子量银耳子实体提取物0.1~5份,海星支管藻提取物5~30份,美丽伊谷草提取物5~30份,库拉索芦荟提取物0.1~15份,其中高分子量银耳子实体提取物分子量为100~500万道尔顿的银耳子实体提取物;低分子量银耳子实体提取物分子量为1~5万道尔顿的银耳子实体提取物。
CN110974775A公开了一种含葛仙米的舒敏组合物及其制备方法和应用,所述含葛仙米舒敏组合物包括藻类提取物和中草药复合提取物。所述组合物包含以下干燥重量份数原料组成:葛仙米5-20份、积雪草1-10份、胀果甘草3-15份、黄芩3-15份、花椒果1-8份、马齿苋5-20份。
从以上公开的技术可以看出,现有的护肤品大都仅仅具有保湿或修复中的一种功能,且在补水保湿以及修复受损肌肤效果方面有待进一步提高。
发明内容
本发明的目的在于提供一种深层补水修复组合物,其护肤品及制备方法,所述深层补水修复组合物原料天然,易于添加在现有护肤品中,以提供卓越的补水保湿以及修复功效。
本发明的技术方案为:
一种深层补水修复组合物,原料组分包括:积雪草根提取物4-6重量份、紫草根提取物0.1-0.2重量份、薄荷叶提取物1-2重量份、金黄洋甘菊提取物1-2重量份、马齿苋提取物1-2重量份、苦参根提取物1-2重量份、库拉索芦荟提取物1-2重量份、香叶天竺葵提取物1-2重量份、仿生类保湿剂6.01-6.03重量份、溶剂10-16重量份、非仿生类保湿剂12-16重量份。
积雪草根提取物,含有多种三萜类,其中包含α-香树脂醇结构。主要成分为积雪草甙,羟基积雪草甙,可以紧致表皮与真皮连接部分,帮助促进真皮层中胶原蛋白形成,使纤维蛋白再生,还可帮助受损的组织愈合及紧实肌肤,使肌肤柔软、紧致。
紫草根提取物,有抗皮肤真菌病毒作用,结合它的抗炎性,皮肤科临床用于治疗扁平疣、银屑病、皮炎、湿疹等;紫草提取物对组织蛋白酶活性有促进作用,提示该提取物可增强皮肤细胞的新陈代谢,结合其抗氧性,有抗衰作用。
薄荷叶提取物,具有刺激中枢神经的功效,作用于皮肤有灼感和冷感。同时,它对感觉神经末梢又有抑制和***作用;因此,可用作抗刺激剂和皮肤***,即对皮肤瘙痒具有抗过敏和止痒作用。
金黄洋甘菊提取物,内含多种黄酮、咖啡酸、糖类、氨基酸等营养成分,具有优异的抗炎消炎、止痛消肿、促进伤口愈合、抗菌止痒、加速溃疡愈合、促进细胞再生、肌肤新陈代谢等优异的药学药理作用。
马齿苋提取物,含有多种具有生理活性的化合物,如氨基酸、多糖、维生素、黄酮、皂苷、生物碱等,具有止痛消炎、抑菌和帮助伤口愈合等作用。具有“天然抗生素”之称,对痢疾杆菌、伤寒杆菌和大肠杆菌有较强的抑制作用,富含蛋白质、维生素、氨基酸、生物碱以及多种微量元素等营养成分,对于祛痘消痕、平滑肌肤具有显著的功效。
苦参根提取物,含生物碱苦参碱、氧化苦参碱。氧化苦参碱具有抗过敏、抗炎作用,能调节免疫和升高白细胞,能够清除下焦湿热,并且杀虫止痒,对皮肤瘙痒有很好的缓解作用。
库拉索芦荟提取物,富含多种有益成分,例如芦荟甙,可作为皮肤的防晒剂,抵御日光侵害;芦荟酊,具有极强的抗菌性,能杀灭多种病菌;其它所含成份如各种糖类、氨基酸、活性酶、芦荟大黄素及小分子营养物质等,均对人体皮肤有极好的滋养作用,可以加速皮肤新陈代谢,增强皮肤弹性,使之显得柔软、光滑、丰满,还可以消除粉刺、雀斑、皲裂,且刺激性少,用后舒适。
香叶天竺葵提取物,其内含的有效成分与天然有机脂具有很强的亲和性,使其大部分营养物质能被肌肤吸收。天竺葵中还含有香茅醇、柠檬醛、薄荷酮和多种微量矿物元素等营养成分,具有止痛、收敛抗菌、增强细胞防御功能等功能,能够深层洁肤,平衡皮脂分泌,促进皮肤细胞新生,修复疤痕。除此之外,它还具有强效的抗氧化、清除自由基功效。
本发明所述的仿生类保湿剂,是指与人体皮肤亲和度高,本身存在于皮肤角质层细胞内,或与其在结构及功能上具有高度相似性,能提高肌肤吸水、锁水能力,以模拟角质细胞内的天然保湿因子(NMF)功效的一类物质。所述仿生类保湿剂优选自透明质酸钠、胶原蛋白、胶原多肽、胶原低聚肽、氨基酸、乳酸盐、尿素、吡咯烷酮羧酸钠、尿囊素、神经酰胺中的任意一种或几种。更优选的,所述仿生类保湿剂为透明质酸钠和胶原低聚肽的混合物。透明质酸钠本身是人体皮肤的构成之一,是人体内分布最广的一种酸性黏糖,存在于***的基质中,具有良好的保湿作用。胶原低聚肽与大分子的胶原蛋白相比,能够被皮肤更好的吸收,其不仅可以在表皮形成保湿膜,赋予角质层中的角质细胞亲水性,还可以渗透到真皮层,实现从表皮到真皮的立体保湿效果,起到深层补水保湿,使皮肤柔软有弹性。更优选的,所述仿生类保湿剂为透明质酸钠和胶原低聚肽按重量比0.01-0.03:5-7组成的混合物。所述胶原低聚肽优选为寡肽-1、寡肽-2、寡肽-3、寡肽-5按重量比1-2:1-2:1-2:1-2组成的混合物。
本发明通过将植物提取成分与仿生类保湿剂进行复配,极大地改善了单独采用植物提取成分见效较慢,效果不明显以及效果持续性较差的问题。且本发明组合物原料天然安全,符合绿色天然化妆品的现代护肤诉求,易于添加在各种类型的护肤品中,以提供卓越的保湿以及修复功效。
本发明所述积雪草根提取物优选为羟基积雪草苷含量>12wt%的积雪草根提取物,所述紫草根提取物优选为水溶性紫草素含量≥0.5wt%的紫草根提取物。通过对以上两种原料中代表性功效成分的含量进行控制,能够极大的保证组合物的实际使用功效,进而保证本发明在补水保湿以及修复受损肌肤方面的效果。
本发明所述溶剂优选为多元醇类,具体可以是甘油、丙二醇、丁二醇、戊二醇中的任意一种或几种的混合物,所述非仿生类保湿剂优选为甜菜碱、甘油聚醚-26的混合物。
一种制备前面所述深层补水修复组合物的方法,包括如下步骤:
(1)将溶剂、非仿生类保湿剂、透明质酸钠混合后加热至80-85℃使溶解完全,得到溶液1;
(2)将溶液1降温至50-55℃,然后加入积雪草根提取物,搅拌均匀,得到溶液2;
(3)将溶液2降温至40-45℃,然后加入剩余各原料,搅拌均匀,即得。
本发明所述深层补水修复组合物的基础上,通过添加化妆品辅料基质,按照化妆品常规工艺可制成常规形式的护肤品。所述化妆品辅料基质包括但不限于1、保湿剂,例如甘油、丙二醇、丁二醇等;2、增稠剂,例如硬脂酸、月桂醇、黄原胶、卡波姆、羧甲基纤维素、羟乙基纤维素等;3、乳化剂,例如鲸蜡硬脂基葡糖苷、PEG-100硬脂酸酯、吐温类等;4、润肤剂,例如辛酸/癸酸甘油三酯、碳酸二辛酯、角鲨烷、生育酚乙酸酯、环五聚二甲基硅氧烷、辛基聚甲基硅氧烷、异十二烷、聚二甲基硅氧烷等,5、防腐剂,例如尼泊金类、山梨酸类、苯氧乙醇、苯甲醇、苯甲酸钠等;6、抗氧剂,例如维生素E、BHT等;7、香精;8、颜料。将本发明所述深层补水修复组合物用于制备护肤品时,各化妆品辅料基质的具体添加量可为化妆品技术领域的常规用量,所述常规形式的护肤品包括具有相对的流动性并且其外观可以是水剂、膏霜、乳液、洗液、面膜中的任意一种。所述深层补水修复组合物在护肤品中的添加量为1-5wt%。
本发明的有益效果为:
1、本发明所述的深层补水修复组合物,添加了包括积雪草根提取物、紫草根提取物、薄荷叶提取物、金黄洋甘菊提取物、马齿苋提取物、苦参根提取物、库拉索芦荟提取物以及香叶天竺葵提取物在内的8种植物提取物,通过将其与仿生类保湿剂进行复配,最终形成的组合物,具有较好的补水保湿、退红舒敏、镇定以及修复受损肌肤的作用。
2、本发明组合物适用产品广,易于添加在多种形式的护肤品中,能轻松制备出外观漂亮的护肤品。
3、本发明组合物质地清爽不黏腻,成分安全温和无刺激,吸收好,还具有一定的改善蚊虫叮咬后的症状的功效。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚,下面将对本发明的技术方案进行详细的描述。显然,所描述的实施例仅仅是本发明的一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动的前提下所得到的所有其它实施方式,都属于本发明所保护的范围。
以下实施例中,积雪草根提取物购自上海珈凯生物科技有限公司,其中,羟基积雪草苷含量为12.6wt%;紫草根提取物购自亿利耐雀生物科技有限公司,其中,水溶性紫草素含量为0.5wt%;薄荷叶提取物、金黄洋甘菊提取物、马齿苋提取物、苦参根提取物、库拉索芦荟提取物、香叶天竺葵提取物均购自NCK。
表1深层补水修复组合物配方
制备方法为:
(1)按上述配比称取各原料,将甘油、丁二醇、甜菜碱、甘油聚醚-26以及透明质酸钠(对比例3省去)加入乳化锅中,加热至80℃使溶解完全,得到溶液1;
(2)将溶液1降温至55℃,然后加入积雪草根提取物,搅拌均匀,得到溶液2;(对比例1省去该步骤)
(3)将溶液2降温至45℃,然后加入剩余各原料,搅拌均匀,即得。
以上述深层补水修复组合物制备面霜,面霜配方以及制备方法如下:
表2面霜配方
制备方法为:
(1)将A相各原料加入油相锅中,加热至85℃,搅拌使溶解均匀,得到油相;
(2)将B相各原料加入水相锅中,加热至90℃,搅拌使溶解均匀,得到水相;
(3)将油相抽入水相锅中,3500r/min均质5min,继续搅拌10min,待降温至45℃时,加入C相各原料,搅拌均匀,即得。
本发明补水效果试验研究
随机选取年龄在25-40岁的60名志愿者,将所有志愿者分为1#面霜组、2#面霜组、3#面霜组、4#面霜组、5#面霜组以及市售保湿面霜组共6组,每组10人,各组在年龄分布、皮肤含水量方面均无显著性差异,具有可比性。所有志愿者暂停其它面部护肤品2天,并于试验开始前清洁面部,之后将对应样品按1.0mg/cm2的用量均匀涂抹于面部,每天早晚各使用1次,分别于第1次使用前以及连续使用2周、4周后,清洁面部,使用电容法皮肤测定仪进行皮肤含水量测试,分别于受试者两侧脸颊、额头、鼻翼以及下巴区域处各取一个位置进行测量,对同一测试区域测量5次,取所有区域皮肤含水量的平均值。
表3补水效果试验结果
结果表明,添加本发明实施例3组合物的2#面霜组在使用前,与其它各组在皮肤含水量方面情况接近,但在连续使用2周以及4周后,皮肤含水量较其余各组增长明显更优,说明本发明实施例3组合物各原料配比最为合理,各组分之间相互配合,取得了较为突出的补水保湿效果。
本发明晒后修复效果试验研究
随机选取30名皮肤晒伤的志愿者,表现为暴露部位可见弥漫性红斑,边界清楚,局部可自觉灼痛。将所有志愿者随机分为2组,每组15名,各组先用清水清洁晒伤部位,然后分别使用2#面霜以及市售晒后修复面霜,按1.0mg/cm2的用量均匀涂抹,每天早晚各使用一次,连续使用2天后,按以下标准对使用效果进行统计:显效:红斑基本消失,灼热及痛感完全消除;有效:红斑减轻50%-80%,边界明显变淡,灼热及痛感明显减轻;无效:红斑变化不明显或减轻程度小于50%;结果见表4。
表4晒后修复效果试验结果
组别 | 显效人数 | 有效人数 | 无效人数 | 总有效率 |
2#面霜组 | 5 | 9 | 1 | 93.33% |
市售晒后修复面霜组 | 0 | 10 | 5 | 66.67% |
结果表明,添加本发明实施例3组合物的2#面霜对晒后肌肤具有很好的修复作用,较市售产品具有明显优势,说明本发明具有较好的退红舒敏、修复受损肌肤的作用。
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应以所述权利要求的保护范围为准。
Claims (10)
1.一种深层补水修复组合物,其特征在于,原料组分包括:
积雪草根提取物4-6重量份、紫草根提取物0.1-0.2重量份、薄荷叶提取物1-2重量份、金黄洋甘菊提取物1-2重量份、马齿苋提取物1-2重量份、苦参根提取物1-2重量份、库拉索芦荟提取物1-2重量份、香叶天竺葵提取物1-2重量份、仿生类保湿剂6.01-6.03重量份、溶剂10-16重量份、非仿生类保湿剂12-16重量份。
2.根据权利要求1所述的深层补水修复组合物,其特征在于,所述积雪草根提取物中,羟基积雪草苷含量>12wt%;所述紫草根提取物中,水溶性紫草素含量≥0.5wt%。
3.根据权利要求1所述的深层补水修复组合物,其特征在于,所述仿生类保湿剂包括透明质酸钠、胶原蛋白、胶原多肽、胶原低聚肽、氨基酸、乳酸盐、尿素、吡咯烷酮羧酸钠、尿囊素、神经酰胺中的任意一种或几种。
4.根据权利要求3所述的深层补水修复组合物,其特征在于,所述仿生类保湿剂为透明质酸钠和胶原低聚肽的混合物。
5.根据权利要求4所述的深层补水修复组合物,其特征在于,所述仿生类保湿剂为透明质酸钠和胶原低聚肽按重量比0.01-0.03:5-7组成的混合物。
6.根据权利要求3-5任一项所述的深层补水修复组合物,其特征在于,所述胶原低聚肽为寡肽-1、寡肽-2、寡肽-3、寡肽-5按重量比1-2:1-2:1-2:1-2组成的混合物。
7.根据权利要求1所述的深层补水修复组合物,其特征在于,所述溶剂为多元醇类,所述非仿生类保湿剂为甜菜碱、甘油聚醚-26的混合物。
8.一种制备权利要求4所述深层补水修复组合物的方法,其特征在于,包括如下步骤:
(1)将溶剂、非仿生类保湿剂、透明质酸钠混合后加热至80-85℃使溶解完全,得到溶液1;
(2)将溶液1降温至50-55℃,然后加入积雪草根提取物,搅拌均匀,得到溶液2;
(3)将溶液2降温至40-45℃,然后加入剩余各原料,搅拌均匀,即得。
9.一种护肤品,其特征在于,由权利要求1所述深层补水修复组合物和化妆品辅料基质组成。
10.根据权利要求9所述的护肤品,其特征在于,所述护肤品为水剂、膏霜、乳液、洗液、面膜中的任意一种,所述深层补水修复组合物在所述护肤品中的添加量为1-5wt%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010511800.5A CN111529450A (zh) | 2020-06-08 | 2020-06-08 | 深层补水修复组合物,其护肤品及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010511800.5A CN111529450A (zh) | 2020-06-08 | 2020-06-08 | 深层补水修复组合物,其护肤品及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111529450A true CN111529450A (zh) | 2020-08-14 |
Family
ID=71968507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010511800.5A Pending CN111529450A (zh) | 2020-06-08 | 2020-06-08 | 深层补水修复组合物,其护肤品及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111529450A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112057397A (zh) * | 2020-09-12 | 2020-12-11 | 荣鼎(广东)生物科技有限公司 | 一种胶原赋活原液类化妆品及其制备方法 |
CN112641701A (zh) * | 2020-12-25 | 2021-04-13 | 云南科妍医药生物科技有限公司 | 一种美白祛斑组合物、修护霜及其制备方法 |
CN114306147A (zh) * | 2021-05-20 | 2022-04-12 | 广州基米生物科技有限公司 | 一种修护面膜组合物、制品及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150342854A1 (en) * | 2012-12-27 | 2015-12-03 | Hayashibara Co., Ltd. | External dermal composition for anti-ageing and method for producing the same |
CN107714585A (zh) * | 2017-11-09 | 2018-02-23 | 董虎 | 含有积雪草提取物的保湿霜 |
CN110075030A (zh) * | 2019-05-17 | 2019-08-02 | 亚享生物科技(江苏)有限公司 | 一种深层修复膏及其制备方法 |
-
2020
- 2020-06-08 CN CN202010511800.5A patent/CN111529450A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150342854A1 (en) * | 2012-12-27 | 2015-12-03 | Hayashibara Co., Ltd. | External dermal composition for anti-ageing and method for producing the same |
CN107714585A (zh) * | 2017-11-09 | 2018-02-23 | 董虎 | 含有积雪草提取物的保湿霜 |
CN110075030A (zh) * | 2019-05-17 | 2019-08-02 | 亚享生物科技(江苏)有限公司 | 一种深层修复膏及其制备方法 |
Non-Patent Citations (1)
Title |
---|
盈妆生物科技(上海)有限公司: "海诗妍水之源焕颜乳霜", 《HTTPS://HZPBA.NMPA.GOV.CN/GCCX/CHAKANHIS.HTML?PRODID=20200813165015ZGR9X&GB=G》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112057397A (zh) * | 2020-09-12 | 2020-12-11 | 荣鼎(广东)生物科技有限公司 | 一种胶原赋活原液类化妆品及其制备方法 |
CN112641701A (zh) * | 2020-12-25 | 2021-04-13 | 云南科妍医药生物科技有限公司 | 一种美白祛斑组合物、修护霜及其制备方法 |
CN114306147A (zh) * | 2021-05-20 | 2022-04-12 | 广州基米生物科技有限公司 | 一种修护面膜组合物、制品及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108969446B (zh) | 一种增强皮肤屏障功能的婴幼儿防皴护肤组合物及其制备方法 | |
CN109288764B (zh) | 一种纯露喷雾及其制备方法 | |
CN111166683A (zh) | 一种富勒烯抗衰抗氧化美容护肤化妆品及其制备方法 | |
CN111529450A (zh) | 深层补水修复组合物,其护肤品及制备方法 | |
CN104586695A (zh) | 含仙人掌精华具有深度补水保湿功效的护肤品 | |
CN113197836A (zh) | 一种保湿舒缓止痒护肤乳霜及其制备方法 | |
CN111956573A (zh) | 一种婴儿水分霜及其制备方法 | |
KR101114161B1 (ko) | 알로에 베라 추출물 및 마쉬맬로우 뿌리 추출물을 함유하는피부 보습용 또는 진정용 인체 세정제 조성물 | |
CN111973486A (zh) | 一种神经酰胺滋润保湿霜及其制备方法 | |
CN113712883A (zh) | 一种含铁皮石斛提取物的修护霜及其制备方法 | |
KR20090038285A (ko) | 꿀풀잎 추출물 및 알로에 베라 추출물을 함유하는 피부보습용 화장료 조성물 | |
CN112402308A (zh) | 一种多效舒缓保湿水及其制备方法 | |
KR20110052095A (ko) | 흰목이 버섯 추출물을 함유하는 피부 보습용 화장료 조성물 | |
KR100979143B1 (ko) | 생약추출물을 유효성분으로 함유하는 피부보습 및탄력개선용 화장료 조성물 | |
CN110721101A (zh) | 一种可自行调配的双组份精华霜及其制备方法 | |
CN112057386A (zh) | 一种清爽保湿美白修复的防晒乳及其制备方法 | |
CN108542820B (zh) | 透皮吸收促进剂、护肤基质及其制备方法和应用 | |
KR101436819B1 (ko) | 피부 보습, 진정 및 여드름 개선용 화장료 조성물 | |
KR100574233B1 (ko) | 피부 보습 및 항자극 효과를 가지는 식물 혼합추출물을함유하는 화장료 조성물 | |
CN110946776A (zh) | 一种含有金蝉提取物成分的肌肤保养霜及其制备方法 | |
CN115813831B (zh) | 一种具有抗敏舒缓功效的组合物及其应用 | |
CN110856708A (zh) | 一种面膜液及其制备方法 | |
CN116459169B (zh) | 一种抗炎保湿皮肤外用组合物及其制备方法和应用 | |
KR102233707B1 (ko) | 천연 추출물 및 천연 가루를 포함하는 화장료 조성물 | |
CN115554217B (zh) | 一种消肿、祛皱的平衡霜及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200814 |
|
RJ01 | Rejection of invention patent application after publication |